Simultaneous measurement of F2-isoprostane, hydroxyoctadecadienoic acid, hydroxyeicosatetraenoic acid, and hydroxycholesterols from physiological samples

Analytical Biochemistry

Volumn 379, Issue 1, 2008, Pages 105-115

  Yoshida, Yasukazu ^a   Kodai, Shintaro ^b   Takemura, Shigekazu ^b   Minamiyama, Yukiko ^b   Niki, Etsuo ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Biomarker; F2 isoprostane; GC MS; LC MS MS; Oxidative stress; tHETE; tHODE; Total analysis

Indexed keywords

BIOMARKERS; CHLORINE COMPOUNDS; LIPIDS; OXIDATIVE STRESS; POTASSIUM HYDROXIDE; SODIUM BOROHYDRIDE; STEREOCHEMISTRY; VIRUSES;

GC-MS; ISOPROSTANES; LC-MS/MS; THETE; THODE; TOTAL ANALYSIS;

LINOLEIC ACID;

ACETIC ACID ETHYL ESTER; CHLOROFORM; CHOLESTEROL DERIVATIVE; GAMMA ISO PROSTAGLANDIN F2 ALPHA; HYDROXYICOSATETRAENOIC ACID; HYDROXYOCTADECADIENOIC ACID; ISOPROSTANE DERIVATIVE; LINOLEIC ACID; POTASSIUM HYDROXIDE; PROSTAGLANDIN F2 ALPHA; SODIUM BOROHYDRIDE; UNSATURATED FATTY ACID;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HEPATITIS B; HEPATITIS C; HUMAN; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MEASUREMENT; PRIORITY JOURNAL; STEREOISOMERISM; BLOOD; CHEMISTRY; LIVER; MASS FRAGMENTOGRAPHY; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

AGED; CHROMATOGRAPHY, LIQUID; F2-ISOPROSTANES; FATTY ACIDS, UNSATURATED; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYDROXYCHOLESTEROLS; HYDROXYEICOSATETRAENOIC ACIDS; LIPID PEROXIDATION; LIVER; MALE; MIDDLE AGED; OXIDATIVE STRESS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 45049087415     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2008.04.028     Document Type: Article

References (42)

1. Halliwell B., and Gutteridge J.M.C. Free Radicals in Biology and Medicine. 3rd ed. (1999), Oxford University Press, Oxford, UK
2. Niki E., Yoshida Y., Saito Y., and Noguchi N. Lipid peroxidation: Mechanisms, inhibition, and biological effects. Biochem. Biophys. Res. Commun. 338 (2005) 668-676
3. Morrow J.D., Harris T.M., and Roberts II L.J. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoids. Anal. Biochem. 184 (1990) 1-10
4. 2 -isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. USA 89 (1992) 10721-10725
5. Basu S. Isoprostanes: Novel bioactive products of lipid peroxidation. Free Radic. Res. 38 (2004) 105-122
6. Fessel J.P., Porter N.A., Moore K.P., Sheller J.R., and Roberts II L.J. Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proc. Natl. Acad. Sci. USA 99 (2002) 16713-16718
7. 2α, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/gas chromatography-mass spectrometry: Basal levels in smokers and nonsmokers. Free Radic. Biol. Med. 20 (1996) 619-624
8. Obata T., Tamura K., Nagakura T., Izumi Y., and Kawamoto T. Smoking and oxidant stress: Assay of isoprostanes in human urine by gas chromatography-mass spectrometry. J. Chromatgr. B 746 (2000) 11-15
9. Montine T.J., Neely M.D., Quinn J.F., Beal M.F., Markesbery W.R., Roberts II L.J., and Morrow J.D. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic. Biol. Med. 33 (2002) 620-626
10. 2 -isoprostanes in human atherosclerotic lesions. J. Clin. Invest. 100 (1997) 2028-2034
11. 2 -isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arterioscl. Thromb. Vac. Biol. 17 (1997) 3236-3241
12. Elbekai R.H., and El-Kadi A.O.C. Cytochrome P450 enzymes: Central players in cardiovascular health and disease. Pharmacol. Ther. 112 (2006) 564-587
13. Wang M.H., Guan H., Nguyen X., Zand B.A., Nasjletti A., and Laniado-Schwartzman M. Contribution of cytochrome P450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in kidneys. Am. J. Physiol. 2 (1999) F246-F253
14. Jira W., Spiteller G., Carson W., and Schramm A. Strong increase in hydroxy fatty acids derived from linoleic acid in human low density lipoproteins of atherosclerotic patients. Chem. Phys. Lipids 91 (1998) 1-11
15. Inouye M., Mio T., and Sumino K. Formation of 9-hydroxy linoleic acid as a product of phospholipid peroxidation in diabetic erythrocyte membranes. Biochim. Biophys. Acta 1438 (1999) 204-212
16. Cho H., Gallaher D.D., and Csallany A.S. Nonradiometric HPLC measurement of 13(S)-hydroxyoctadecadienoic acid from rat tissues. Anal. Biochem. 318 (2003) 47-51
17. Schwarzer E., Kühn H., Valente E., and Arese P. Malaria-parasitized erythrocytes and hemozoin nonenzymatically generate large amounts of hydroxy fatty acids that inhibit monocyte functions. Blood 101 (2003) 722-728
18. Yoshida Y., Itoh N., Hayakawa M., Piga R., Cynshi O., Jishage K., and Niki E. Lipid peroxidation induced by carbon tetrachloride and its inhibition by antioxidant as evaluated by an oxidative stress marker, HODE. Toxicol. Appl. Pharmacol. 208 (2005) 87-97
19. Yoshida Y., Itoh N., Hayakawa M., Habuchi Y., Inoue R., Chen Z.H., Cao J., Cynshi O., and Niki E. Lipid peroxidation in mice fed choline-deficient diet and its inhibition by antioxidants as evaluated by an oxidative stress marker, HODE. Nutrition 22 (2006) 303-311
20. Yoshida Y., and Niki E. Bio-markers of lipid peroxidation in vivo: Hydroxyoctadecadienoic acid and hydroxycholesterol. BioFactors 27 (2006) 195-202
21. Yoshida Y., Hayakawa M., Habuchi Y., and Niki E. Evaluation of the dietary effects of coenzyme Q in vivo by the oxidative stress marker, hydroxyoctadecadienoic acid, and its stereoisomer ratio. Biochim. Biophys. Acta 1760 (2006) 1558-1568
22. Tanito M., Yoshida Y., Kaidzu S., Chen Z.H., Cynshi O., Jishage K., Niki E., and Ohira A. Acceleration of age-related changes in the retinal structure and biochemistry in α-tocopherol transfer protein null mice fed with a vitamin E-deficient diet. Invest. Ophthalmol. Vis. Sci. 48 (2007) 396-404
23. 2α. Anal. Chim. Acta 585 (2006) 86-93
24. Yoshida Y., Saito Y., Hayakawa M., Habuchi Y., Imai Y., Sawai Y., and Niki E. Levels of lipid peroxidation in human plasma and erythrocytes: Comparison between fatty acids and cholesterol. Lipids 42 (2007) 439-449
25. Y. Yoshida, A. Yoshikawa, T. Kinumi, Y. Ogawa, Y. Saito, K. Ohara, H. Yamamoto, Y. Imai, E. Niki, Hydroxyoctadecadienoic acid and oxidatively modified peroxiredoxins in the blood of Alzheimer's disease patients and their potential as biomarkers, Neurobiol. Aging (in press).
26. Yoshida Y., Hayakawa M., Itoh N., Habuchi Y., Inoue R., Chen Z.H., Cao J., Cynshi O., Jishage K., and Niki E. Antioxidant effects of 2,3-dihydro-5-hydroxy-4,6-di- tert -butyl-2,2-dipentylbenzofuran and α-tocopherol in hyperlipidemic mice as evaluated by hydroxyoctadecadienoic acid and 7-hydroxycholesterol. Biochem. Pharmacol. 74 (2007) 1010-1019
27. Dzeletovic S., Breuer O., Lund E., and Diczfalusy U. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 225 (1995) 73-80
28. Brown A.J., Leong S., Dean R.T., and Jessup W.J. 7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque. J. Lipid Res. 38 (1997) 1730-1745
29. Brown A.J., and Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 142 (1999) 1-28
30. Ishii K., Adachi J., Tomita M., Kurosaka M., and Ueno Y. Oxysterols as indices of oxidative stress in man after paraquat ingestion. Free Radic. Res. 36 (2002) 163-168
31. Pikuleva L.A. Cholesterol-metabolizing cytochromes P450. Drug Metab. Dispos. 34 (2006) 513-520
32. Smith L.L., and Johnson B.H. Biological activities of oxysterols. Free Radic. Biol. Med. 7 (1989) 285-332
33. Sevanian A., Seraglia R., Traldi P., Rossato P., Ursini F., and Hodis H. Analysis of plasma cholesterol oxidation products using gas and high-performance liquid chromatography/mass spectrometry. Free Radic. Biol. Med. 17 (1994) 397-409
34. Diczfalusy U. Analysis of cholesterol oxidation products in biological samples. J. AOAC Intl. 87 (2004) 467-473
35. Kühn H., and Borchert A. Regulation of enzymatic lipid peroxidation: The interplay of peroxidizing and peroxide reducing enzymes. Free Radic. Biol. Med. 33 (2002) 154-172
36. Dufour C., and Loonis M. Regio- and stereoselective oxidation of linoleic acid bound to serum albumin: Identification by ESI-mass spectrometry and NMR of the oxidation products. Chem. Phys. Lipids 138 (2005) 60-68
37. Kühn H., Heydeck D., Hugou I., and Gniwotta C. In vivo action of 15-lipoxygenase in early stages of human atherogenesis. J. Clin. Invest. 99 (1997) 888-893
38. Yamashita H., Nakamura A., Noguchi N., Niki E., and Kühn H. Oxidation of low density lipoprotein and plasma by 15-lipoxygenase and free radicals. FEBS Lett. 445 (1999) 287-290
39. Yoshida Y., Hayakawa M., Habuchi Y., Itoh N., and Niki E. Evaluation of lipophilic antioxidant efficacy in vivo by the biomarkers hydroxyoctadecadienoic acid and isoprostane. Lipids 42 (2007) 463-472
40. Moore K. Isoprostanes and the liver. J. Lipid Res. 128 (2004) 125-133
41. Esworthy R.S., Chu F.F., Geiger P., Girotti A.W., and Doroshow J.H. Reactivity of plasma glutathione peroxidase with hydroperoxide substrates and glutathione. Arch. Biochem. Biophys. 307 (1993) 29-34
42. Hurst R., Bao Y., Ridley S., and Williamson G. Phospholipid hydroperoxide cysteine peroxidase activity of human serum albumin. Biochem. J. 338 (1999) 723-728